U.S. Tobacco Stock News

Bank of America has delivered a 124.4% gain over the past 3 years, which naturally pushes investors to ask whether that share price now lines up with the returns the bank earns on its capital. Recent headlines around interest rates, unrealized bond losses and fee income only sharpen the focus on what the current valuation assumes about how efficiently this financial giant can keep using its balance sheet. Over 3 years the stock has climbed 124.4%, so the question is how much of that...

Coinbase Global moved higher recently as crypto related stocks responded to new SEC tokenization rules, a sharp Bitcoin recovery, and fresh attention on the company’s derivatives efforts after its CFTC filing for perpetual futures on major U.S. equities. The combination of SEC tokenization guidance and Coinbase Global’s push into perpetual futures highlights how regulatory clarity and product expansion could reshape its revenue mix away from purely spot crypto trading. Now the focus shifts...

On Holding has seen a sharp reset in its share price this year, and the size of that pullback puts a fresh spotlight on whether the current valuation can still be explained by its earnings power. With the stock now trading around US$27.26, the key issue is how that price lines up against what the business is actually generating in profit. The share price is down about 41.9% year to date, which puts pressure on the idea that the current market value reflects what the underlying earnings can...

FedEx (FDX) just rolled out FedEx Authenticated Delivery, a QR code based service aimed at tighter control over high value and sensitive parcels in the U.S. and Canada, giving investors a fresh product move to assess. FedEx shares have softened recently, with the 30 day share price return down 6.6% and the 90 day return down 7.6%, yet the 1 year total shareholder return of 65.5% and 5 year total shareholder return of 83.9% point to strong longer term momentum as the company rolls out new...

Pagaya Technologies (NasdaqCM:PGY) appointed Marqeta founder Jason Gardner to its Board of Directors. Gardner brings more than 20 years of fintech and payments experience, including leading Marqeta through its IPO. His board role aligns with Pagaya's focus on AI-driven lending marketplace products and payment technology. The Jason Gardner board appointment is important, but investors should weigh it alongside other Pagaya developments. Our analysis turns up 2 warning signs for Pagaya...

Digital Realty Trust (DLR) has been drawing fresh attention after a run of AI focused moves, including a new AXG partnership, the rollout of ServiceFabric MCP, a joint venture in Türkiye, and an expanded Nairobi campus. Recent trading tells a mixed story for Digital Realty Trust. The share price has eased over the past week and quarter, with the 7 day share price return down 3.43% and the 90 day share price return down 6.86%. However, the year to date share price return of 17.47% and 3 year...

MGE Energy has seen a mixed share price record in recent years, with the stock pulling back over the past 12 months after earlier gains. That leaves investors weighing whether the current price around US$74 is adequately supported by the utility's future stream of dividend payments. Over the past 5 years, MGE Energy has delivered a total return of 9.9%, which puts real weight on the question of how much of that experience can reasonably be tied to its dividend profile. The group runs a...

Linde (LIN) grabbed investor attention after its latest share price move, with the industrial gas specialist now trading around $460.40 per share on the Nasdaq. Short term performance has been mixed. Recent trading has been choppy for Linde, with the 30 day share price return down 5.57% and the 90 day share price return lower by 10.90%, even though the year to date share price return is still up 7.29%. That pullback contrasts with a 1 year total shareholder return that is slightly negative at...

Recent market research points to significant projected expansion in global RNA interference therapeutics, with Alnylam Pharmaceuticals identified as a leading participant in RNA-based treatments for hard-to-treat conditions, including hereditary transthyretin-mediated amyloidosis. The emphasis on rare disease prevalence and precision medicine investment highlights how Alnylam Pharmaceuticals's focus on hATTR and RNAi platforms ties directly into an expanding treatment universe and potential...

The latest move in FuelCell Energy (FCEL) has been sparked by legislation, not earnings. The U.S. House passed the Ratepayer Protection Act, which shifts grid upgrade costs for heavy power users such as large data centers. For context, FuelCell Energy’s recent move comes after a sharp year-to-date share price return of 121.66% and a 1-year total shareholder return of 116.63%. However, momentum has faded in recent months, with a 30-day share price return down 7.32% and a 90-day share price...

BNY (NYSE:BNY) has lost its role as depositary bank for Kazia Therapeutics' American Depositary Receipt program. Kazia Therapeutics has appointed JPMorgan Chase as the new depositary for its ADR program, replacing Bank of New York Mellon Corporation. The ADR depositary switch highlights competitive pressure on BNY's global custody and asset servicing franchise. The move by Kazia Therapeutics to shift its ADR depositary from BNY to JPMorgan Chase tells only part of the story. Take a look at 1...

Novo Nordisk (NYSE:NVO) received a positive opinion from the European Medicines Agency's CHMP for Sogroya as a treatment for idiopathic short stature in children. If approved by the European Commission, Sogroya could become the first authorised therapy for idiopathic short stature in the EU pediatric population. The opinion supports Novo Nordisk's effort to expand its rare disease and pediatric endocrinology portfolio beyond existing growth hormone deficiency indications. The CHMP backing...

Pulse Biosciences (NasdaqCM: PLSE) reported completion of 100 patient enrollment in its PRECISE-BTN thyroid nodule study using the nPulse Vybrance Percutaneous Electrode System. The PRECISE-BTN trial expanded from an original 50 patients to 100 patients across multiple participating centers. Management plans future disclosure of clinical data from PRECISE-BTN, which is intended to support potential regulatory clearance for nPulse Vybrance. The completed PRECISE-BTN enrollment matters, but it...

TTM Technologies has delivered very large gains over the past five years, which puts a sharp focus on whether the current US$117.97 share price lines up with the cash flows that support the business. With an intrinsic value estimate based on a Discounted Cash Flow (DCF) model available, the key issue is how that cash flow view compares with a stock that has already rewarded early holders in a big way. Over 5 years, the stock is up about 8x. Anyone looking at TTM Technologies today has to ask...

DHT Holdings announced a three year time charter for the 2016 built VLCC DHT Panther at a rate of $100,000 per day with a global energy company, with the contract starting in October 2026. The fixed multi year charter on a modern VLCC locks in contracted revenue for DHT Holdings and provides greater visibility on fleet utilization compared with relying purely on spot exposure. We will look at how DHT Holdings' investment narrative around cash flow stability is affected by the $100,000 daily...

T. Rowe Price Group recently launched three fully transparent actively managed equity ETFs on the NASDAQ, targeting biotech, U.S. small caps, and U.S. mid caps, with expense ratios between 0.47% and 0.59%. The new ETFs broaden T. Rowe Price Group’s active ETF shelf across key equity segments, which may support more diversified fee streams and help address competitive pressure from lower cost passive products. We will look at how T. Rowe Price Group’s investment narrative intersects with this...

Recent commentary on AMC Entertainment Holdings (AMC) points to a stronger film slate and higher demand for premium formats. This is lifting attendance and sentiment even as investors continue to watch the company’s leverage closely. At a share price of US$2.70, AMC Entertainment Holdings has seen a 7 day share price return of 9.76% and a year to date share price return of 67.70%, yet the 1 year total shareholder return has declined 10.30%, signalling that recent momentum contrasts with a...

Pfizer recently presented at the Morgan Stanley 24th Annual Global Healthcare Conference in New York, with CEO Albert Bourla outlining how the business is handling debt, patent expiries, and future product opportunities. The discussion put a spotlight on how Pfizer balances a large dividend outlay and more than US$60b of acquisition driven debt with the need to fund its oncology, obesity, and vaccine pipelines. We will now look at how Pfizer's investment narrative could be affected by CEO...

Trip.com Group (NasdaqGS: TCOM) has introduced Agent ONE, an AI-powered suite under its Trip.Biz unit for corporate travel management. Agent ONE is designed to shorten booking times for employees and give travel managers centralized oversight of business trips and compliance. The launch signals a push by Trip.com Group to expand beyond leisure customers into global corporate travel using artificial intelligence tools. The Agent ONE rollout within Trip.Biz comes alongside broader shifts our...

Upstart Holdings has seen its share price come under heavy pressure in recent years, and that slide puts a spotlight on a simple question for you as an investor. Is the current valuation of Upstart stock still supported by what the business is earning today and what those earnings suggest it could deliver over time. Over the past 5 years, the share price has fallen about 92.4%, which puts a lot of weight on whether the remaining market value lines up with the company’s earnings power. The...

Universal (UVV) drew fresh attention after terminating J. Patrick O’Keefe, Vice President of Ingredients, without cause on September 15, 2026, while continuing its previously announced search for his successor. Universal’s share price has eased in recent months, with the stock down 14.3% over 90 days and 16.1% year to date at US$44.14. Longer term total shareholder returns of 11.2% over three years and 25.9% over five years point to a more resilient history despite recent weakness. Capitalize...

W. P. Carey has delivered solid long term gains for holders, even as more recent trading has been choppy. That puts a spotlight on whether the earnings behind the stock now justify the current price. With real estate investors also watching fresh company updates, the question is how much of the underlying profit story is already reflected in that US$66.26 closing level. Over the past 3 years the stock has returned 40.2%, which raises the stakes on whether the current earnings profile can...

Berkshire Hathaway (BRK.A) moved back into the spotlight after Warren Buffett stepped down as chairman and became Chairman Emeritus, with long-time director Howard Buffett taking over the board role. Recent boardroom headlines have arrived while Berkshire Hathaway’s 1 month share price return of 2.70% and 3 month share price return of 3.98% point to steady, if measured, momentum, with a 1 year total shareholder return of 3.13% and a 5 year total shareholder return of 82.64% reminding...

Mattel announced a new Thomas & Friends animated special, Really Helpful Engines, along with a refreshed Railway Stories series and reimagined global toy line, plus a separate multi-year licensing deal bringing Bluey into Barbie, Hot Wheels, Fisher-Price, Polly Pocket and UNO products. The twin push into fresh Thomas content tied directly to a redesigned Easy Connect track system and a broad Bluey licensing rollout deepens Mattel’s use of owned and partner IP across both streaming and...